InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $1.400 0.08 (6.06%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$43 Notice under section 708A 28 Nov 2024 5:13PM $0.007 $1.400 risen by 19,900%
$43 Application for quotation of securities - OSL 28 Nov 2024 5:09PM $0.007 $1.400 risen by 19,900%
$43 Proposed issue of securities - OSL 27 Nov 2024 6:01PM $0.007 $1.400 risen by 19,900%
$43 Results of Meeting 20 Nov 2024 6:01PM $0.007 $1.400 risen by 19,900%
$43 AGM Chairman's Address and CEO & MD Presentation 20 Nov 2024 3:42PM $0.008 $1.400 risen by 18,566.67%
$43 OncoSil Signs Distribution Agreements for Nordics and Egypt 18 Nov 2024 8:24AM $0.008 $1.400 risen by 17,400%
$43 Investor Webinar Presentation 15 Nov 2024 9:48AM $0.009 $1.400 risen by 15,455.56%
$43 Investor Webinar 13 Nov 2024 12:58PM $0.008 $1.400 risen by 17,400%
$43 Notice of Extraordinary General Meeting December 2024 12 Nov 2024 8:26AM $0.008 $1.400 risen by 18,566.67%
$43 First OncoSil Treatment at Instituto Nazionale dei Tumori 11 Nov 2024 8:32AM $0.007 $1.400 risen by 19,900%
$43 Change in substantial holding from SOL 6 Nov 2024 11:06AM $0.008 $1.400 risen by 17,400%
$43 Prospectus 2024 Share Purchase Plan (SPP) Offer 6 Nov 2024 8:22AM $0.008 $1.400 risen by 17,400%
$43 Change in substantial holding from PCG 5 Nov 2024 3:00PM $0.008 $1.400 risen by 17,400%
$43 Notice under section 708A 1 Nov 2024 9:31AM $0.008 $1.400 risen by 17,400%
$43 Application for quotation of securities - OSL 1 Nov 2024 9:24AM $0.008 $1.400 risen by 17,400%
$43 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 9:04AM $0.009 $1.400 risen by 15,455.56%
$43 Amended Share Purchase Plan (SPP) Timetable 30 Oct 2024 10:02AM $0.010 $1.400 risen by 13,900%
$43 Update - Proposed issue of securities - OSL 29 Oct 2024 6:41PM $0.010 $1.400 risen by 13,900%
$43 OncoSil Appoints Rachel Duggan as EMEA Sales Director 29 Oct 2024 9:35AM $0.011 $1.400 risen by 12,627.27%
$43 Proposed issue of securities - OSL 28 Oct 2024 9:53AM $0.013 $1.400 risen by 10,669.23%
$43 Capital Raise Presentation 28 Oct 2024 9:37AM $0.013 $1.400 risen by 10,669.23%
$43 Proposed issue of securities - OSL 28 Oct 2024 9:21AM $0.013 $1.400 risen by 10,669.23%
$43 Proposed issue of securities - OSL 28 Oct 2024 9:05AM $0.013 $1.400 risen by 10,669.23%
$43 OSL completes $7 M Placement and announces $1 M SPP 28 Oct 2024 9:05AM $0.013 $1.400 risen by 10,669.23%
$43 G-BA Approval received for OncoSil Device 24 Oct 2024 9:56AM $0.013 $1.400 risen by 10,669.23%

176 - 200 of 784 results

Page 8 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.